Home Ingredients DIM (Diindolylmethane)
Women's HealthMen's Health

DIM (Diindolylmethane)

Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

DIM (3,3'-diindolylmethane) is a metabolite of indole-3-carbinol (I3C) — formed in the stomach from cruciferous vegetables (broccoli, cabbage, kale, cauliflower, brussels sprouts). Used to support healthy estrogen metabolism by promoting the 2-hydroxyestrone pathway over the 16-alpha-hydroxyestrone pathway. Popular in women's health protocols for hormonal balance, PMS, fibrocystic breasts, and as adjunct in estrogen-related conditions. Often combined with calcium D-glucarate.

Studied Dose 100-300 mg/day; trials commonly 100-200 mg/day; bioavailability-enhanced forms (BioResponse-DIM®, microencapsulated) at lower doses
Active Compound 3,3'-diindolylmethane (DIM)

Benefits

Estrogen Metabolism Modulation

DIM shifts estrogen metabolism toward the 2-hydroxyestrone pathway (considered 'protective') and away from 16-alpha-hydroxyestrone (considered 'proliferative'). Dalessandri 2004 trial showed DIM 108 mg/day modified estrogen metabolite ratios in women with breast cancer history. Foundational mechanism for hormonal applications.

Supported by Trial 1, Trial 2

PMS / Premenstrual Symptom Support

Used clinically by integrative practitioners for PMS, mood swings, breast tenderness, water retention. Limited rigorous RCT evidence; mechanism plausible via estrogen metabolism modulation.

Supported by Trial 1

Fibrocystic Breast Support

Reduces breast tenderness and fibrocystic changes in some women. Component of integrative protocols. Limited high-quality clinical evidence.

Supported by Trial 1

Cervical Dysplasia Adjunct (HPV-Related)

Del Priore 2010 trial showed DIM (2 mg/kg/day) reduced cervical intraepithelial neoplasia (CIN) progression in some women with abnormal Pap smears. Adjunct only — not replacement for standard cervical cancer screening and treatment.

Supported by Trial 2

Detoxification Support / Phase II Conjugation

Supports phase II liver detoxification pathways (sulfation, glucuronidation) — relevant for clearing estrogens, environmental toxins, and metabolic byproducts.

Mechanism of action

1

CYP1A1 / CYP1A2 Induction (Estrogen 2-Hydroxylation)

DIM induces CYP1A1 and CYP1A2 enzymes — these convert estradiol to 2-hydroxyestrone (vs the alternative 16-alpha-hydroxyestrone pathway via CYP3A4). 2-OH estrone is considered 'weak/protective'; 16-alpha-OH estrone is more 'proliferative'. Shifts estrogen metabolism balance.

2

Aromatase Modest Inhibition

Mild aromatase inhibition — reduces conversion of androgens to estrogens. Effect modest at supplemental doses; relevant in women's health and bodybuilding contexts.

3

Aryl Hydrocarbon Receptor (AhR) Modulation

DIM is an AhR ligand — modulates this nuclear receptor that controls multiple xenobiotic metabolism genes. Supports detoxification pathway expression.

4

Anti-Estrogen Receptor Effects

DIM has weak antiestrogenic activity at estrogen receptor alpha — competes with estradiol for binding. May contribute to effects in estrogen-sensitive conditions.

Clinical trials

1
DIM for Estrogen Metabolism — Dalessandri 2004
PubMed

RCT of DIM (108 mg/day) vs placebo in 19 postmenopausal women with breast cancer history for 30 days.

19 postmenopausal women with breast cancer history.

Significantly increased 2-OH estrone:16-alpha-OH estrone ratio (favorable shift). Established DIM modifies estrogen metabolism as proposed. Small study; longer-term and clinical outcome data limited.

2
DIM for Cervical Dysplasia — Del Priore 2010
PubMed

RCT of DIM (2 mg/kg/day) vs placebo in 64 women with CIN 2 or 3 for 12 weeks.

64 women with CIN 2/3.

DIM showed trend toward improvement in CIN; not statistically robust. Generated continuing research interest. Adjunct only — standard cervical cancer screening/treatment remains foundational.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Yellow-orange discoloration of urine — common, harmless (DIM metabolite).
GI distress.
Headache.
Skin reactions / rash rare.
Estrogen-mimetic OR antagonistic symptoms in sensitive individuals — mood changes, menstrual irregularities, breast tenderness initially.
Body odor changes (sulfur-based metabolites).
Initial 'detox' symptoms — fatigue, headache (theoretical; usually transient).

Important Drug interactions

ESTROGEN-CONTAINING MEDICATIONS (oral contraceptives, HRT) — DIM accelerates estrogen metabolism; may reduce contraceptive efficacy; consult prescriber; consider alternative or backup contraception.
TAMOXIFEN — theoretical interaction; mixed effects on tamoxifen metabolism; consult oncologist.
CYP1A2 SUBSTRATES (caffeine, tizanidine, theophylline, mexiletine, certain antidepressants) — DIM induces CYP1A2; may reduce levels of these medications.
CYP1A1 substrates — similar concerns.
Hormone-sensitive cancers — theoretical complex effects; consult oncologist before use.
Pregnancy/lactation — limited safety data; AVOID supplementation.

More Women's Health Ingredients

Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Kidney/Urinary Tract
MannoHealth™ (D-Mannose — Bioenergy Life Science)
MannoHealth™ is a HIGH-PURITY D-MANNOSE ingredient from Bioenergy Life Science (BLS) — dis…
Menopause Support
FenuSmart® (Fenugreek for Menopause — Akay Bioactives)
FenuSmart® is a PATENTED FULL-SPECTRUM FENUGREEK SEED EXTRACT (Trigonella foenum-graecum)…
Kidney/Urinary Tract
Pacran® (Whole Cranberry Powder — Naturex)
Pacran® is a WHOLE CRANBERRY POWDER (Vaccinium macrocarpon) developed by Naturex (now Giva…

Explore Other Ingredients

Men's Health
Nettle Root (Urtica dioica)
Stinging nettle ROOT (distinct from leaf, which has different uses) is used for benign pro…
Men's Health
Pumpkin Seed Oil (Cucurbita pepo)
Pumpkin seed oil is cold-pressed oil from pumpkin seeds — particularly from STYRIAN pumpki…
Cognitive
Mucuna Pruriens (Velvet Bean / Kapikacchu)
Mucuna pruriens (also called velvet bean, cowitch, kapikacchu) is a tropical legume distin…

Frequently asked questions about DIM (Diindolylmethane)

What is the recommended dosage of DIM (Diindolylmethane)?

The clinically studied dose for DIM (Diindolylmethane) is 100-300 mg/day; trials commonly 100-200 mg/day; bioavailability-enhanced forms (BioResponse-DIM®, microencapsulated) at lower doses. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is DIM (Diindolylmethane) used for?

DIM (Diindolylmethane) is studied for estrogen metabolism modulation, pms / premenstrual symptom support, fibrocystic breast support. DIM shifts estrogen metabolism toward the 2-hydroxyestrone pathway (considered 'protective') and away from 16-alpha-hydroxyestrone (considered 'proliferative').

Are there side effects from taking DIM (Diindolylmethane)?

Reported potential side effects may include: Generally well-tolerated. Yellow-orange discoloration of urine — common, harmless (DIM metabolite). Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does DIM (Diindolylmethane) interact with medications?

Known drug interactions may include: ESTROGEN-CONTAINING MEDICATIONS (oral contraceptives, HRT) — DIM accelerates estrogen metabolism; may reduce contraceptive efficacy; consult prescriber; consider alternative or backup contraception. TAMOXIFEN — theoretical interaction; mixed effects on tamoxifen metabolism; consult oncologist. Consult a pharmacist or healthcare provider if you take prescription medications.

Is DIM (Diindolylmethane) good for women's health?

Yes, DIM (Diindolylmethane) is researched for Women's Health support. DIM shifts estrogen metabolism toward the 2-hydroxyestrone pathway (considered 'protective') and away from 16-alpha-hydroxyestrone (considered 'proliferative'). Dalessandri 2004 trial showed DIM 108 mg/day modified estrogen metabolite ratios in women with breast cancer history.